Escherichia coli RNA polymerase-promoter complex were cross-linked to the ␤ subunit. Using limited proteolysis and chemical degradation, the cross-link was mapped to a segment of ␤ between amino acids Val 516 and Arg 540 . This region (Rif-cluster I) is known to harbor many rifampicin-resistant (Rif R ) mutations. The results demonstrate that Rif-cluster I is part of the "5-face" of the active center and provide structural basis for the long-known effects of Rif R mutations on transcription initiation, elongation, and termination.
The cellular multisubunit DNA-dependent RNA polymerase is the central enzyme of gene expression and a target for genetic regulation. The two largest subunits of RNA polymerase (RNAP) 1 display a remarkable degree of evolutionary conservation (1, 2) . The best studied RNAP is that of Escherichia coli. The catalytically competent core RNAP consists of the ␤Ј (1,407 amino acid residues), the ␤ (1,342 residues), and the two ␣ (329 residues) subunits (3) . The holoenzyme composed of the core and a subunit is able to specifically initiate transcription from promoters (4) . The initiation reaction begins with the binding of a priming substrate (usually a purine nucleotide) and the next nucleoside triphosphate to the holoenzyme stably anchored at the promoter DNA. RNAP then catalyzes the formation of the first phosphodiester bond, yielding a dinucleotide and pyrophosphate.
In order to identify amino acid residues participating in the active center of RNAP, we took the approach of mapping the sites of chemical cross-linking of substrate analogs. Using probes specific for Lys and His residues, we showed that evolutionary conserved Lys 1065 and His 1237 near the C terminus of the ␤ subunit are located at the "5Ј face" of the priming ATP (5) (6) (7) . Here, we use a broadly specific alkylating cross-linkable group placed on the 5Ј side of the initiating NTP to implicate another site of the ␤ subunit in the active center.
Three short regions in the middle of the ␤ subunit defined by mutations of resistance to Rif, Rif-cluster I (amino acids 512-534), Rif-cluster II (amino acids 563-574), and Rif-cluster III (amino acid 687), have long been suspected of involvement in the RNAP active center. The assumption rested on the Rif ability to block extension of short initial transcripts (8) , the failure of Rif R mutants to bind Rif (9) , and elongation defects observed in certain Rif R mutants (10 -12) . However, all of these effects could be explained by allosteric mechanisms whereby Rif R mutations and/or Rif would exert their effects at a distance. Recently, we presented direct evidence positioning the Rif binding site shortly upstream of the catalytic center (13) in accord with the model that Rif plugs the product exit channel (8) . Yet, there is still no rigorous proof that mutationally defined Rif-clusters in the middle of ␤ participate directly in Rif binding site or in the RNAP active center. Our present results directly position Rif-cluster I at the 5Ј face of the initiating NTP site.
MATERIALS AND METHODS

Affinity Reagents
The iodo-containing derivatives of ATP, ADP, and AMP were obtained as follows.
[N,N-bis-(2-Iodoethyl)]aminobenzaldehyde-100 mg of 4-[N,N-bis-(2chloroethyl)]aminobenzaldehyde was placed in a solution containing 200 mg of NaI in 1 ml of dimethylformamide and incubated at 95°C for 4 h. The mixture was supplemented with 3 ml of water and extracted with an equal volume of ether. Organic phase was collected and evaporated to dryness under vacuum. The product was recrystallized from methyl alcohol.
Alkylation of ATP, ADP, and AMP-10 mg of ATP, ADP, or AMP (triethylammonium salts) in 100 l of water was mixed with 20 mg of [N,N-bis-(2-iodoethyl)]aminobenzaldehyde in 200 l of (dimethylaminomethyl)phenol, and 10 l of diisopropylethylamine was added. After 3-4 h at 60°C, the mixture was applied on a silica gel plate and developed in an acetonitrile/water (4:1) system. Reaction product was visualized under UV light and/or by color reaction with 2,4-dinitrophenylhydrazine, eluted with water, and lyophilized.
Affinity Labeling
10-l reactions contained 40 mM Tris-HCl, pH 7.9, 100 mM KCl, 10 mM MgCl 2 , ϳ1.0 g of RNAP, and 0.5-1.0 mM derivatized initiating substrate. Reactions were supplemented with 10 mM BH 4 and incubated at 37°C for 10 min. Reactions were supplemented with 100 ng of 136-base pair T7 A1 promoter-containing DNA fragment (14) generated by polymerase chain reaction, [␣-32 P]UTP (3,000 Ci/mmol) was added to 0.3 M, and incubation continued for 30 min at 23°C. In experiment shown on Fig. 4 , affinity modification of ⍀H 6 RNAP was performed in the presence of promoter fragment, and reaction was scaled up 5 times. Control experiments demonstrated that the resulting 32 P-labeling of RNAP depended on the addition of the template DNA (data not shown). 
Cross-linked Product Analysis
Electrophoresis in the presence of SDS was carried out in precast polyacrylamide gels (Novex). Conditions of WT and ⍀T989 RNAP trypsin treatment are described in detail elsewhere (15, 16) . Purification of the cross-linked polypeptides from the gel and conditions of complete CNBr degradation were essentially as described (17) .
For Ni 2ϩ NTA agarose affinity purification, CNBr cleavage reactions were dried down under vacuum and resuspended in 200 -500 l of buffer containing 6 M urea and 100 mM Tris-HCl, pH 7.6. An aliquot was withdrawn for electrophoretic analysis, 25-50 l of Ni 2ϩ resin was washed in the urea buffer added, and reactions were gently mixed for 30 min at 4°C. After a brief centrifugation, the sorbent was washed 3 times with 1.5 ml of the urea buffer and then 2 times with 1.5 ml of transcription buffer. The buffer was then removed and the bound protein was eluted in a small volume of SDS-containing Laemmli loading buffer in the presence of 25 mM EDTA. For BNPS-skatole treatment, the affinity-purified CNBr fragment was eluted from Ni 2ϩ NTA agarose by addition of 3 volumes of glacial acetic acid. 1 volume of BNPS-skatole (10 mg/ml) in 70% acetic acid was added to the eluate, and reaction was incubated for 10 h at room temperature, extracted to dryness with ether, and the solid residue was dissolved in SDS-containing Laemmli loading buffer.
RNA Polymerases
RNAP was reconstituted as described (18) . Detailed characterization of the reconstituted ⍀T989 and ⍀H 6 enzymes is described in Refs. 16 and 19, respectively.
RESULTS
The Experimental System-The task of introducing and mapping of a cross-link on the RNAP molecule is complicated by the fact that the enzyme is composed of 5 polypeptides with the cumulative molecular mass of ϳ500 kDa. To introduce the cross-linking probe, we employ the highly selective affinity labeling protocol (5, 6) which leads to a radioactive dinucleotide group selectively cross-linked in the vicinity of the active center. The first step of the procedure consists of derivatization of the binary RNAP-promoter complex with a nonradioactive cross-linkable analog of the priming nucleotide (ATP). The second step allows the derivatized complex to incorporate the next radioactive nucleotide ([␣-32 P]NTP). Hence, only those cross-linked probes that are faithfully positioned in the priming site of the active center would be extended to yield the radioactive dinucleotide reporter group.
For the high resolution mapping of the cross-links, we employ genetically engineered catalytically proficient variants of RNAP with conveniently located sites that facilitate analysis, i.e. a highly labile proteolysis site about two-thirds down the length of the ␤ subunit (15, 16) and an insertion of six consecutive histidines between Rif-cluster I and Rif-cluster II (19) . The inserted His-tag specifically absorbs to Ni 2ϩ -chelating sorbents and allows one to selectively recover a subset of peptide fragments carrying the tag from a proteolytic digest.
The adenine nucleotide analogs used in this work as the primary cross-linkable reagents are shown on Fig. 1 . The AMP(1065) reagent was used in the previous work (5 -7) . Its aldehyde group cross-links exclusively to the ␤ subunit Lys 1065 (7) . The three other reagents are analogous to the previously described chloro derivatives (5) . The reagents contain an alkylating group that is inactive because of a strong electron-acceptor effect of the aldehyde group. Reduction of the aldehyde group in the presence of NaBH 4 results in a 1000-fold increase of the alkylating activity. The iodo-containing derivatives used in this work are ϳ100 times more reactive than the corresponding chloro compounds, and the alkylating reaction proceeds with a half-life of 5 min at room temperature (data not shown). The alkylating group can react with any nucleophilic amino acid side chain (Cys, His, Lys, Tyr, Asp, Glu, Ser, Thr). However, alkylated Glu and Asp residues are unstable and do not survive SDS-polyacrylamide gel electrophoresis conditions. 
Broad Specificity Active Center Reagent Cross-links at Two
Sites of the ␤ Subunit-In the experiment of Fig. 2, A and B , RNAP in open complexes on A1 promoter of bacteriophage T7 was cross-linked to reagents shown in Fig. 1 . Derivatized complexes were then incubated in the presence of [␣-32 P]UTP to develop the cross-link.The results of highly selective affinity labeling of WT RNAP using ATP* as the primary cross-linking reagent are presented in Fig. 2A, lane 1 . The slower migrating radioactive band comigrated with RNAP large subunits, which were not resolved at the 8% SDS-gel used in this experiment. The faster migrating band comigrated with the subunit (17) .
When small amounts of trypsin were added to completed modification reactions, two new radioactive bands with apparent molecular size of ϳ90 and ϳ40 kDa appeared (lanes 2 and  3) . In the control experiment with AMP(1065) reagent, only the 40-kDa fragment was seen in the trypsin-treated reactions (not shown). Elsewhere we show that at the low concentrations used here trypsin predominantly attacks WT RNAP at positions 903 and 909 of ␤, to generate two fragments of ϳ90 (N-terminal) and ϳ40 (C-terminal) kDa (15) . The results suggest that ATP* cross-linked both in the C-terminal third and in the N-terminal two-thirds of the ␤-polypeptide.
Because only a small fraction of the WT RNAP is cleaved under single-hit conditions, we repeated the above experiment with a mutant enzyme carrying a highly labile proteolysis site approximately two-thirds down the length of the ␤-polypeptide. The mutant ⍀T989 RNAP is indistinguishable from the WT enzyme in functional tests, but is much more sensitive to trypsin attack due to an insertion of ϳ130 amino acids at position 989 (15, 16) . Fig. 2B shows the results of an experiment where ⍀T989 RNAP was modified with different reagents and then subjected to mild treatment with trypsin. When ⍀T989 RNAP modified with the lysine-specific reagent AMP(1065) (lane 1) was treated with trypsin, all of the radioactivity was found in the C-terminal fragment of mutant ␤ (lane 2). The alkylating cross-linkable group positioned at the ␣-, ␤-, and ␥-phosphates of initiating adenosine nucleotide, labeled both the smaller (C-terminal) and the larger (N-terminal) fragments of ⍀T989 ␤ (lanes 4, 6, and 8, respectively) . In trypsin-treated affinity labeling reactions, the part of the gel corresponding to intact large subunits contained little or no radioactivity, testifying that ␤Ј was not appreciably labeled by any of the reagents.
Rifampicin decreased the overall efficiency of labeling with ATP* reagent (lane 9), but did not inhibit cross-linking of the N-terminal part of ␤ (lane 10) (in fact, the ratio of the N-to C-terminal fragment labeling increased in the presence of rifampicin).
Mapping of the Cross-link in the N-terminal Part of the ␤ Subunit-To map the cross-link site in the N-terminal part of the ⍀T989 ␤ subunit, the radioactive N-terminal fragments of ␤ shown in Fig. 2B were excised from the gel and subjected to complete CNBr degradation (Fig. 3) . As a control, the C-terminal fragment of the ⍀T989 ␤ subunit labeled at Lys 1065 with the lysine-specific reagent was also subjected to CNBr treatment (lane 5) yielding a single labeled polypeptide with an apparent molecular mass of 11 kDa (expectant molecular size ϳ10,200 kDa). Thus, under these conditions, CNBr degradation of ␤ proceeded to completion.
Two major radioactive peptides were generated when Nterminal fragments of ⍀T989 ␤-labeled with alkylating reagents were subjected to CNBr treatment. The larger peptide had an apparent molecular mass of ϳ18 kDa, the smaller, ϳ4 kDa. The ratio of the two peptides depended on the affinity Fig. 1 . The reactions were treated with trypsin as indicated and were then loaded on an 8% Tris-glycine polyacrylamide SDS-gel. The cross-linked RNAP subunits were visualized by autoradiography. In B, small amounts of radioactive ␤ C fragment visible in the lanes corresponding to reactions that were not treated with trypsin are due to a very high sensitivity of ⍀T989 RNAP to proteolytic attack which occurs to some extent during the enzyme preparation. The proteolyzed enzyme retains its catalytic activity (16) and is therefore labeled in the assay.
FIG. 3. Complete CNBr degradation of cross-linked N-terminal
␤ fragments. The radioactive ␤ N polypeptides shown in Fig. 2B were extracted from the gel and treated with CNBr. Reaction products were separated on a 16% Tris-Tricine polyacrylamide-SDS gel, and radioactive peptides were visualized by autoradiography. labeling reagent. The smaller peptide predominated when AMP* was used (lane 1), while the larger was dominant when RNAP was labeled with ATP* (lane 4). In the presence of Rif, the amount of the smaller peptide cross-linked to ATP* decreased even further (lane 5).
Since CNBr cleavage was complete, the 18-kDa labeled peptide should come from between two Met residues separated by ϳ140 amino acids. From the sequence of the N-terminal tryptic fragment of ␤, the likely candidate is the fragment between Met 515 and Met 653 . This was further tested using a mutant ⍀H 6 RNAP which carried a stretch of 8 amino acids, Ile-(His) 6 -Trp, inserted between ␤ positions 540 and 541 (19) . The ⍀H 6 RNAP is fully functional in vivo and in vitro (19) . Preliminary experiments showed that the modified ⍀H 6 enzyme gave the same pattern of radioactive fragments upon trypsin cleavage as the control WT RNAP (not shown). If the site of the ATP* cross-link in the N-terminal part of ⍀H 6 ␤ subunit were indeed between Met 515 and Met 653 , we should be able to purify the histidine-tagged, cross-linked ⍀H 6 ␤ CNBr fragment by affinity chromatography on Ni 2ϩ sorbent.
In the experiment of Fig. 4 , the ⍀H 6 RNAP was affinitylabeled using ATP*, and an excess of unlabeled ⍀H 6 ␤ subunit carrier was added so that the material could be visualized both by staining (lane 1) and autoradiography (lane 6). The CNBr reaction products shown (lanes 2 and 7) were loaded on Ni 2ϩ NTA resin in the presence of 6 M urea and washed extensively. As expected, CNBr-generated peptide Val 516 -Met 653 was retained on the sorbent as revealed by Coomassie staining (lane 3). Since the peptide was radioactively labeled (lane 8), we conclude that the site of the major ATP* cross-link in the N-terminal part of ␤ is contained within the fragment Val 516 -Met 653 . Control experiments established that no polypeptides were retained on Ni 2ϩ NTA resin when WT RNAP was used in the modification reaction (data not shown).
To further localize the site of the ATP* cross-link, we made use of the Trp residue inserted immediately past the six histidines in the ⍀H 6 RNAP. The inserted Trp is unique to the Val 516 -Met 653 peptide. The affinity-purified Val 516 -Met 653 peptide was subjected to treatment with BNPS-skatole, a reagent which specifically cleaves polypeptides after Trp residues. As is shown on Fig. 4, lane 4 , BNPS-skatole generated two peptides with the apparent mobility of 5 and 11 kDa (expectant molecular sizes are 3,678 Da and 12,850 Da, respectively). The smaller peptide was radioactive, while the larger was not (Fig.  4, lane 9) . The larger BNPS-skatole peptide was lost during the second round of affinity purification, while the smaller peptide as well as the initial Val 516 -Met 653 peptide were retained on the sorbent (lanes 5 and 10). We conclude that the site of the ATP* cross-link is contained within the ␤ subunit fragment between Val 516 and Arg 540 .
DISCUSSION
The impetus for this work came from an earlier study (20) . 2 The authors mapped a cross-linking site of a 5Ј-chloro derivative of ATP between residues 516 and 653 of the WT ␤ subunit. In the turmoil of disintegration of the Soviet Union, these data were irreversibly lost, and we decided to reinvestigate the issue using a more powerful family of iodo-derivatized reagents and recombinant mutant RNA polymerases.
Our present results demonstrate that the ␤ subunit segment between residues 516 and 540 contains the site(s) of crosslinking to ATP*. This site should be located within 5 Å of the ␥-phosphate of the priming ATP, which is the effective range of the probe used. The distance between the Rif-cluster I and the C-terminal ␤ localities labeled by the same reagent should not exceed this distance more than twice. Hence, these two regions which are separated in the linear sequence of ␤ by more than 500 amino acids must be juxtaposed in the folded ternary 2 A. Mustaev, E. Zaychikov, and M. Grachev, unpublished results.
FIG. 4. Localization of ATP*-crosslink site in ⍀H 6 ␤. A, the bar at the top represents the 1342-amino acid-long ␤-polypeptide, with lettered boxes symbolizing highly conserved sequence regions (1) . The Rif region (10) and amino acids in the C-terminal part of ␤ that form the 5Ј-face of the active center (6, 7) are indicated. Underneath, successive steps of chemical degradation of modified ⍀H 6 ␤ are schematized, corresponding to experimental data in B. The cleavage sites that follow from ⍀H 6 ␤ sequence are shown by arrows. Radioactive ␤ fragments are shown in black, the rest of the polypeptide is shaded. B, ⍀H 6 RNAP was modified with ATP*. Purified recombinant ⍀H 6 ␤ subunit was added (lanes 1 and 6) , and complete CNBr degradation was performed (lanes 2 and 7) . After affinity purification on Ni 2ϩ sorbent (lanes 3 and 8) , the bound material was treated with BNPS-skatole (lanes 4 and 9) , dried, loaded on Ni 2ϩ sorbent, and washed. The bound material is analyzed in lanes 5 and 10. Reaction products were resolved by electrophoresis in a 16% Tris-Tricine gel. The gel was stained with Coomassie (left panel) and autoradiographed (right panel). In lane 6, radioactive bands migrating faster than labeled ␤ result from crosslinking to DNA (17) and disappear upon treatment with DNase (data not shown). The faster migrating radioactive band in lanes 9 and 10 migrates slower than the corresponding Coomassie-stained band in lanes 4 and 5 due to covalently attached radioactive dinucleotide tetraphosphate. structure of the enzyme. Elsewhere we show that part of the conserved domain 3 of 70 , as well as positions Ϫ3 and Ϫ4 of the template DNA strand are in contact with ␥-phosphate of initiating nucleotide (17, 13) . In addition to these elements, other RNAP sites apparently participate in the 5Ј-face of the active center since another, yet unidentified site in the N-terminal part of ␤ is efficiently cross-linked to ADP* and AMP* probes (see Fig.  3 ). Experiments aimed at mapping of these sites are in progress.
Even though Rif-cluster I appears to be in direct contact with the priming substrate, the cross-linked residue is not essential for the enzymatic reaction since the derivatized enzyme is still able to form the phosphodiester bond. The viability of many mutants isolated in this area also argues against its direct involvement in an essential function. On the other hand, the mutant RNA polymerases have been shown to have altered apparent K m values for the reaction substrates during initiation and elongation (11) , as well as changes in factor-dependent and independent termination (10, 21) . These phenotypes are consistent with the notion that the priming nucleotide site overlaps with a larger site holding the RNA product in the active center during elongation. Structural disruption of this area by a mutation may affect the formation and/or proper positioning of the 3Ј-proximal portion of nascent RNA and, hence, result in defects affecting extension of RNA chains.
Our previous work positioned RNAP-bound Rif immediately upstream of the initiating nucleotide binding site (13) . The present results demonstrate that Rif-cluster I is located in the same vicinity adding strength to the notion that Rif R mutations indeed define the Rif binding site.
